RIPE-KG · Version 1.1.0 · Resource

ripekg:author/RIPEAU5796DFE6B48B1B32

https://w3id.org/ripe/ripe-kg/author/RIPEAU5796DFE6B48B1B32
SubjectPredicateObject
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type node1
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type rdfs:Resource
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type owl:Thing
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type prov:Person
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type foaf:Person
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei rdf:type ripe:AuthorAuthor
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei owl:sameAs https://semopenalex.org/author/A5037955819
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei foaf:familyName Wei
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei foaf:givenName Jia-Wang
ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei foaf:name Jia-Wang Wei
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial dcterms:creator ripekg:author/RIPEAU5796DFE6B48B1B32Jia-Wang Wei